AP - Pharmaceutical companies Schering-Plough Corp. and Merck & Co. posted strong sales Monday from their joint venture on cholesterol drugs, but otherwise their third-quarter earnings reports — and investor reaction — were strikingly different.
Tuesday, October 23, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment